Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$30.43 -3.3%	$30.96	$26.25 ▼ $40.49	$15.61B	0.63	4.51 million shs	2.79 million shs
HOLX Hologic	$54.82 -2.9%	$58.47	$51.90 ▼ $84.67	$12.22B	0.54	2.14 million shs	2.71 million shs
MASI Masimo	$149.39 -4.3%	$159.24	$101.61 ▼ $194.88	$8.10B	1.23	652,542 shs	811,181 shs
TFX Teleflex	$121.96 -3.9%	$132.18	$120.06 ▼ $249.91	$5.39B	1.17	635,930 shs	391,172 shs

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	-3.29%	+0.58%	+6.53%	-9.00%	-11.68%
HOLX Hologic	-2.92%	-0.98%	-3.72%	-14.77%	-26.47%
MASI Masimo	-4.34%	-2.46%	+0.10%	-15.70%	+19.97%
TFX Teleflex	-3.72%	-2.62%	-5.70%	-30.36%	-42.74%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAX Baxter International	4.7111 of 5 stars	3.2	3.0	1.7	4.0	2.8	1.7	2.5
HOLX Hologic	4.9713 of 5 stars	4.2	5.0	0.0	4.3	2.8	3.3	2.5
MASI Masimo	4.5312 of 5 stars	3.4	3.0	0.0	4.2	3.5	2.5	1.3
TFX Teleflex	4.9161 of 5 stars	4.0	5.0	2.5	3.9	2.0	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAX Baxter International	2.44	Hold	$37.25	22.43% Upside
HOLX Hologic	2.41	Hold	$77.42	41.22% Upside
MASI Masimo	2.83	Moderate Buy	$191.60	28.25% Upside
TFX Teleflex	2.09	Hold	$164.63	34.98% Upside

Current Analyst Ratings Breakdown

Latest TFX, BAX, HOLX, and MASI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/13/2025	HOLX Hologic	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$77.00 ➝ $70.00
5/7/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$193.00
5/7/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $200.00
5/7/2025	MASI Masimo	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$204.00 ➝ $185.00
5/7/2025	MASI Masimo	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $190.00
5/5/2025	BAX Baxter International	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$30.00 ➝ $28.00
5/5/2025	HOLX Hologic	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$77.00 ➝ $65.00
5/5/2025	TFX Teleflex	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$140.00 ➝ $137.00
5/5/2025	TFX Teleflex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$191.00 ➝ $173.00
5/2/2025	BAX Baxter International	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$36.00 ➝ $33.00
5/2/2025	HOLX Hologic	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$75.00 ➝ $70.00

(Data available from 5/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAX Baxter International	$10.77B	1.45	$4.72 per share	6.45	$16.69 per share	1.82
HOLX Hologic	$4.03B	3.03	$4.69 per share	11.69	$21.27 per share	2.58
MASI Masimo	$2.13B	3.81	$4.86 per share	30.74	$25.79 per share	5.79
TFX Teleflex	$3.01B	1.79	$13.11 per share	9.30	$94.49 per share	1.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAX Baxter International	-$649M	-$1.10	N/A	11.14	0.93	-5.05%	16.67%	4.93%	8/5/2025 (Estimated)
HOLX Hologic	$789.50M	$2.37	17.29	11.87	2.14	18.42%	19.72%	10.94%	8/4/2025 (Estimated)
MASI Masimo	$81.50M	-$9.17	103.03	32.27	N/A	3.85%	14.98%	6.95%	8/5/2025 (Estimated)
TFX Teleflex	$356.33M	$3.17	24.25	8.03	1.73	7.85%	14.19%	8.53%	8/7/2025 (Estimated)

Latest TFX, BAX, HOLX, and MASI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
5/1/2025	Q1 2025	BAX Baxter International	$0.48	$0.62	+$0.14	$0.25	$2.59 billion	$2.63 billion
5/1/2025	Q2 2025	HOLX Hologic	$1.02	$1.03	+$0.01	-$0.08	$1.00 billion	$1.01 billion
5/1/2025	Q1 2025	TFX Teleflex	$2.88	$2.91	+$0.03	$2.07	$699.37 million	$700.67 million
2/27/2025	Q4 2024	TFX Teleflex	$3.86	$3.89	+$0.03	-$2.95	$813.24 million	$795.40 million
2/25/2025	Q4 2024	MASI Masimo	$1.42	$1.80	+$0.38	-$6.52	$593.35 million	$600.70 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAX Baxter International	$0.68	2.24%	-1.40%	N/A	N/A
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.12%	N/A	42.90%	N/A

Latest TFX, BAX, HOLX, and MASI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2025	BAX Baxter International	quarterly	$0.17	2.27%	5/30/2025	5/30/2025	7/1/2025
5/12/2025	TFX Teleflex	quarterly	$0.34	1.09%	5/20/2025	5/20/2025	6/16/2025
2/27/2025	TFX Teleflex	quarterly	$0.34	0.77%	3/7/2025	3/7/2025	3/17/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAX Baxter International	1.31	1.43	1.09
HOLX Hologic	0.52	3.49	2.78
MASI Masimo	0.50	2.01	1.11
TFX Teleflex	0.37	2.42	1.39

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAX Baxter International	90.19%
HOLX Hologic	94.73%
MASI Masimo	85.96%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
BAX Baxter International	0.21%
HOLX Hologic	1.88%
MASI Masimo	16.90%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAX Baxter International	60,000	513.18 million	509.47 million	Optionable
HOLX Hologic	6,940	222.85 million	220.17 million	Optionable
MASI Masimo	6,200	54.22 million	48.35 million	Optionable
TFX Teleflex	15,500	44.19 million	45.78 million	Optionable

TFX, BAX, HOLX, and MASI Headlines

Recent News About These Companies

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

May 21 at 4:00 PM | accessnewswire.com

3 Healthcare Stocks with Questionable Fundamentals

May 21 at 6:26 AM | msn.com

Cresset Asset Management LLC Sells 5,188 Shares of Teleflex Incorporated (NYSE:TFX)

May 21 at 3:51 AM | marketbeat.com

Janus Henderson Enterprise Fund Q1 2025 Commentary

May 20 at 8:24 PM | seekingalpha.com

Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

May 20 at 7:21 PM | prnewswire.com

Millennium Management LLC Has $44.51 Million Position in Teleflex Incorporated (NYSE:TFX)

May 20 at 4:47 AM | marketbeat.com

Equities Analysts Offer Predictions for Teleflex Q3 Earnings

May 20 at 2:09 AM | marketbeat.com

Q3 Earnings Estimate for Teleflex Issued By Zacks Research

May 20 at 2:05 AM | americanbankingnews.com

Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

May 19 at 7:51 PM | globenewswire.com

Teleflex Publishes 2024 Global Impact Report

May 19 at 8:28 AM | markets.businessinsider.com

Teleflex Publishes 2024 Global Impact Report

May 19 at 6:30 AM | globenewswire.com

Siemens Fonds Invest GmbH Buys Shares of 7,507 Teleflex Incorporated (NYSE:TFX)

May 19 at 6:28 AM | marketbeat.com

Fortis Hospitals Partners with Teleflex for Innovative UroLift Training Hub

May 19 at 4:46 AM | devdiscourse.com

City hospital signs MoU with Teleflex to create a UroLift Center of Education for South Asia

May 18, 2025 | thehindu.com

Teleflex Incorporated (NYSE:TFX) Position Raised by Man Group plc

May 18, 2025 | marketbeat.com

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

May 17, 2025 | markets.businessinsider.com

Teleflex: Cheap With Significant Unknowns

May 17, 2025 | seekingalpha.com

Gotham Asset Management LLC Has $4.28 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

May 17, 2025 | marketbeat.com

Occudo Quantitative Strategies LP Makes New Investment in Teleflex Incorporated (NYSE:TFX)

May 16, 2025 | marketbeat.com

Lost Money on Teleflex Incorporated (TFX)? Possible Fraud - Contact Levi & Korsinsky Today

May 15, 2025 | accessnewswire.com

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

May 15, 2025 | accessnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TFX, BAX, HOLX, and MASI Company Descriptions

Baxter International NYSE:BAX

$30.42 -1.04 (-3.29%)

Closing price 05/21/2025 03:59 PM Eastern

Extended Trading

$30.38 -0.04 (-0.13%)

As of 05/21/2025 07:36 PM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Hologic NASDAQ:HOLX

$54.82 -1.65 (-2.92%)

Closing price 05/21/2025 04:00 PM Eastern

Extended Trading

$55.43 +0.61 (+1.12%)

As of 05/21/2025 07:29 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Masimo NASDAQ:MASI

$149.39 -6.78 (-4.34%)

Closing price 05/21/2025 04:00 PM Eastern

Extended Trading

$149.34 -0.04 (-0.03%)

As of 05/21/2025 04:20 PM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Teleflex NYSE:TFX

$121.96 -4.90 (-3.86%)

Closing price 05/21/2025 03:59 PM Eastern

Extended Trading

$122.90 +0.94 (+0.77%)

As of 05/21/2025 07:11 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time